The cluster is dominated by active/quant sellers (Point72, Two Sigma, Morgan Stanley) with a near-exit from Point72, while the sole buyer is a passive index fund. This suggests informed capital is rotating out. Monitor for further 13F filings next quarter to confirm trend; the stock may face continued selling pressure if the thesis weakens.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $21.28entry
- T+1 · 5mo ago +1.93%α +1.39% · $21.69
- T+5 · 5mo ago +7.71%α +7.27% · $22.92
- T+20 · 4mo ago +39.47%α +37.58% · $29.68
- T+60 · 2mo ago +8.88%α +4.49% · $23.17
How similar events traded
Executive Summary
An institutional cluster for Bicara Therapeutics (BCAX) shows net bearish conviction in Q3 2025: 3 sellers (including a near-exit from Point72) versus 1 passive buyer (Schwab). The selling is concentrated among active/quant funds, while the sole buyer is a passive index manager, suggesting the bearish signal is more informative. Total selling value ($1.6M) outweighs buying ($2.6M net, but driven by price appreciation, not conviction).
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.6M
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Schwab | ADD | +45.5% | $4.4M | $2.6M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -51.1% | $1.9M | -$320.0K |
| Two Sigma | TRIM | -29.2% | $1.2M | $255.0K |
| Point72 | NEAR_EXIT | -86.1% | $2.0M | -$1.5M |
Key Facts
- 3 sellers vs 1 buyer in Q3 2025 institutional cluster
- Point72 near-exited 86.1% of its position (from $2.0M to $476K)
- Morgan Stanley trimmed 51.1% of its stake (from $1.9M to $1.6M)
- Two Sigma trimmed 29.2% of its position
- Only buyer was Schwab (passive index fund), adding 45.5% to $4.4M
- Net dollar change across all tracked funds: -$1.6M (sellers) vs +$2.6M (buyer, largely price-driven)
Financial Impact
3 institutional sellers reduced holdings by a net of $1.6M, while 1 passive buyer added $2.6M (mostly from price appreciation). Total tracked institutional activity: $4.2M in gross turnover.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound or reversed since quarter-end
- Small absolute dollar amounts ($1-4M) may not be material for a $1.3B market cap stock
- Passive buying from Schwab could offset some selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BCAX-2025-Q3 |
Track record
26 reports on BCAX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $9.98 settles Dec 8
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $8.89 settles Dec 3
- Nov 4, 202612d ago Press Release Neutral 2/10 Entry $8.89 settles Dec 3
- Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $16.42 to $8.89 ▼ −45.86% −44.52% vs SPY
- Oct 5, 20266w ago Press Release Neutral 2/10 Entry $17.29 to $9.13 ▼ −47.19% −44.73% vs SPY
- Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.78 to $18.35 ▼ −19.45% −18.89% vs SPY
- Aug 25, 202611w ago 8-K Neutral 2/10 Entry $24.73 to $19.78 ▼ −20.02% −20.24% vs SPY
- Aug 14, 202613w ago Press Release Neutral 2/10 Entry $24.28 to $23.20 ▼ −4.45% −2.46% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral Not scored Entry $23.63 to $22.81 ▼ −3.47% −1.72% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $23.63 to $22.81 ▼ −3.47% −1.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers